From formulation development through global clinical trials to final approval, Symbio Proinnovera provides specialized experience and expertise in clinical research. Our global studies have helped pave the way to advancements in dermatology, ophthalmology, women’s health and internal medicine since 2002.
SPECIALISTS IN DERMATOLOGY CLINICAL TRIALS
From North America to Europe to Latin America, our global Clinical Research Organization (CRO) team has managed more than 150 dermatology clinical trials, resulting in over 50 FDA approvals. As leading experts in dermatology research, Symbio Proinnovera specializes in many areas of dermatology trials including, but not limited to Acne, Psoriasis, Atopic Dermatitis, Rosacea, Actinic Keratosis, Tinea Pedis, Onychomycosis and more.
2024 AAD ANNUAL MEETING IS A GREAT SUCCESS
200
Phase 1-4 Clinical Trials
85000
Subjects
1200
Investigators and Clinical Sites
59
FDA Approvals
Home
A Clinical Research Organization that Exceeds All Expectations
Symbio Proinnovera is a client-focused, global Clinical Research Organization (CRO) with world-class qualifications in the development of therapeutic drugs. We provide a full suite of industry-leading services to sponsors, including:
Project Management – experienced project management team that best suits your needs
Data Management – in-house database design and user-friendly electronic data capture
Medical Monitoring Services – in-house Medical Monitor offering over 30 years of experience
BioStatistics – experienced statisticians with extensive knowledge in clinical programs translating clinical thought into statistical data analysis
Site Selection – extensive investigator database
Monitoring – in-house monitors with extensive experience
Medical Writing – fast turnaround times for protocol development and clinical study reports
Subject Recruitment – proactive services to shorten enrollment timelines, track and monitor enrollment
We operate all of the core services of our Clinical Research Organization in-house at offices in both the United States and Europe.
Extensive Experience in Clinical Research
Symbio Proinnovera’s executive leadership team has decades of experience in the clinical development of therapeutic medications. Our experienced personnel strategically manage every aspect of clinical trials. We pride ourselves on providing outstanding service every step of the way, from formulation through to final approval.
In conjunction with our subsidiary, Dow Development Laboratories, LLC, Symbio Proinnovera provides a turnkey CRO solution, which includes the design, development and topical formulation of drug products.
Therapeutic Expertise
Dermatology
Acne
Psoriasis
Atopic Dermatitis
Rosacea
Actinic Keratosis
Tinea Pedis
Onychomycosis
Wound Healing
Seborrheic Keratosis
Dermal Fillers
Alopecia Areata
Basal Cell Carcinomas
Common Warts
Scar Therapy
Hair Regeneration
Impetigo
Secondarily Infected Skin Wounds
Rare Disease
Ophthalmology
Allergic Conjunctivitis
Dry Eye
Glaucoma
Women’s Health
Fibrocystic Breast Disease
Vaginal/Vulvar Atrophy
UTI
Internal Medicine
Allergic Rhinitis
Osteoarthritis
Otitis Externa
Ulcers of Lower Extremities
Internal Hemorrhoids
Insomnia
“The reward for providing great work is being awarded with additional studies and projects. Symbio is here to help Sponsors get studies done – whatever it takes.”
RICHARD PANICO, MBA
President, Symbio, LLC and CEO, Symbio in Europe: SRE GmbH
Symbio Proinnovera
2019-02-03T19:11:06-05:00
“The reward for providing great work is being awarded with additional studies and projects. Symbio is here to help Sponsors get studies done – whatever it takes.” RICHARD PANICO, MBA President, Symbio, LLC and CEO, Symbio in Europe: SRE GmbH
“Clinical research is a huge group effort. Our Symbio staff understands that we are all in this together, we all want to be part of something successful and work hard to make that happen.”
DEBRA DOW, PharmD, MBA
Vice President, Scientific Affairs, Symbio, LLC
Symbio Proinnovera
2019-02-03T19:11:54-05:00
“Clinical research is a huge group effort. Our Symbio staff understands that we are all in this together, we all want to be part of something successful and work hard to make that happen.” DEBRA DOW, PharmD, MBA Vice President, Scientific Affairs, Symbio, LLC
Save the date for March 7 to 11 and get ready to launch your path to dermatologic expertise. Delve into an atmosphere of cutting-edge education led by dermatology experts and
more
The EADV Congress is one of the largest international meetings focused on dermatology and venereology, providing a platform for researchers, clinicians, and industry professionals to exchange knowledge, network, and present their latest research
more
As always, the AAD Annual Meeting was a resounding success. The Symbio Proinnovera team was able to meet with many clients and colleagues to discuss innovations in dermatology. It was
more
PRESS RELEASE Symbio & Dow Group merges with Proinnovera to form leading dermatology CRO, Symbio Proinnovera New York, USA & Münster, Germany – November 16, 2023 The newly announced merger
more
The newest white paper in Symbio’s white paper series was recently released entitled, “Atopic Dermatitis: Considerations for Clinical Trials.” This paper explores the clinical research challenges involved in AD trials
more
Symbio has released their latest white paper “The Clinical State of Psoriasis” which aims to explain why biologics have become so popular and why their introduction has been so disruptive
more
Europe may seem small considering only about 10% of the world’s population lives there, but it’s the second largest region by the number of studies conducted according to clinicaltrials.gov. The
more
